A radically new therapeutic approach that aims to improve the quality of life of cancer patients and beyond: PROSION Therapeutics is a biotech & drug development company with a proprietary "LEGO-like" platform, aiming to address highly unmet medical needs by unlocking undruggable protein targets.Starting off in oncology, our mission is to develop new drugs against hard-to-treat diseases. As of 2022, PROSION is backed by the European Commission and European deeptech investor Freigeist Capital.